Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Roche Holding AG (OTCQX International Premier:RHHVF)

243.56
Real-Time Quote
As of 2:41pm ET
 -4.44 / -1.79%
Today’s Change
216.45
Today|||52-Week Range
276.80
+6.85%
Year-to-Date
Biogen (BIIB) Q3 Earnings: Will it Deliver a Beat Again?
Oct 18 / Zacks.com - Paid Partner Content
Mylan Gets Complete Response Letter For Biosimilar Neulasta
Oct 11 / Zacks.com - Paid Partner Content
ImmunoGen to Push Leukemia Candidate into Phase I Trial
Oct 17 / Zacks.com - Paid Partner Content
Clovis (CLVS) Submits sNDA for Ovarian Cancer Drug Rubraca
Oct 10 / Zacks.com - Paid Partner Content
Inovio Initiates Bladder Cancer Study With Roche's Tecentriq
Oct 17 / Zacks.com - Paid Partner Content
AstraZeneca's Tagrisso Gets Breakthrough Therapy Designation
Oct 09 / Zacks.com - Paid Partner Content
FDA Grants Priority Review for Exelixis' RCC Drug Cabomteyx
Oct 17 / Zacks.com - Paid Partner Content
Roche (RHHBY) Receives FDA Approval For Cobas Zika Test
Oct 09 / Zacks.com - Paid Partner Content
Foreign Stock Roundup: Roche Gets FDA Nod for Zika Test, Shell to Buy NewMotion
Oct 16 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why
Oct 05 / Zacks.com - Paid Partner Content
Merck Will Not Seek Approval for CETP Inhibitor Anacetrapib
Oct 12 / Zacks.com - Paid Partner Content